Nearly $ 30 Billion growth expected in Global Type 2 Diabetes Market during 2021-2025 | Technavio
NEW YORK , June 14, 2021 /PRNewswire/ - The type 2 diabetes market is expected to grow by USD 29.91 billion during 2021-2025, according to Technavio. The report offers a detailed analysis of the impact of the COVID-19 pandemic on the type 2 diabetes market in optimistic, probable, and pessimistic forecast scenarios.
Request a Free Sample to understand the scope of the report
The type 2 diabetes market will witness a neutral impact during the forecast period owing to the widespread growth of the COVID-19 pandemic. As per Technavio's pandemic-focused market research, market growth is likely to increase in 2021 as compared to 2020.
With the continuing spread of the coronavirus pandemic, organizations across the globe are gradually flattening their recessionary curve by leveraging technology. Many businesses will go through response, recovery, and renewal phases. Building business resilience and enabling agility will aid organizations to move forward in their journey out of the COVID-19 crisis towards the Next Normal.
Key Considerations for Market Forecast:
- Impact of lockdowns, supply chain disruptions, demand destruction, and change in customer behavior
- Optimistic, probable, and pessimistic scenarios for all markets as the impact of pandemic unfolds
- Pre- as well as post-COVID-19 market estimates
- Quarterly impact analysis and updates on market estimates
The type 2 diabetes market is driven by the rising prevalence of diabetes. In addition, a rise in the prevalence of obesity and changing lifestyles and recent drug approvals are expected to trigger the type 2 diabetes market toward witnessing a CAGR of about 10% during the forecast period.
Gain more insights into the global trends impacting the future of the type 2 diabetes market.
Request Free Sample @ https://www.technavio.com/talk-to-us?report=IRTNTR70605
Major Five Type 2 Diabetes Market Participants:
Amgen Inc.: The company offers type 2 diabetes products such as Repatha.
AstraZeneca Plc: The company offers type 2 diabetes products such as Komboglyze, Onglyza, and XIGDUO XR.
Boehringer Ingelheim International GmbH: The company offers type 2 diabetes products such as Glyxambi and Jardiance.
Novo Nordisk AS: The company offers type 2 diabetes products such as Tresiba and Xultophy.
Sanofi SA: The company offers type 2 diabetes products such as Adlyxin, Amryl, Lantus, Toujeo, and Apidra.
Type 2 Diabetes Market 2021-2025: Segmentation
Type 2 diabetes market is segmented as below:
- North America
- Drug Class
- DPP-4 Inhibitors
- GLP-1 Receptor Agonists
- SGLT-2 Inhibitors
Related Reports on Healthcare Include:
Global Type 1 Diabetes Drugs Market - Global type 1 diabetes drugs market is segmented by product (long-acting insulins, rapid-acting insulins, pre-mixed insulins, and non-insulin drugs) and geography ( North America , Europe , Asia , and ROW).
Request a Free Sample Report
Global Diabetes Management Devices Market - Global diabetes management devices market is segmented by product (blood glucose monitoring devices and insulin delivery systems) and geography ( North America , Europe , Asia , and ROW).
Request a Free Sample Report
Gain instant access to 17,000+ market research reports by using
Technavio's SUBSCRIPTION platform
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
View original content to download multimedia: http://www.prnewswire.com/news-releases/nearly--30-billion-growth-expected-in-global-type-2-diabetes-market-during-2021-2025--technavio-301310792.html